Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Vaxart Stock Is Surging As Its Oral COVID-19 Vaccine Can Potentially Trigger Immunity Against Variants
Vaxart Slides After Reporting Delay Of Trial For Potential COVID-19 Oral Vaccine
Article By:
The Fly
Monday, May 3, 2021 3:08 PM EDT
Shares of Vaxart are under pressure on Monday after the company reported worse-than-expected first quarter losses and said that its Phase II trial of VXA-CoV2-1 is now expected to start mid-year 2021 instead of in the second quarter.
In this article: VXRT
US Stock Market Weekly Review Aug. 23-28
Article By:
Stavros Georgiadis
Saturday, August 29, 2020 11:49 PM EDT
The valuations of stocks at these new record highs are of major concern.
Vaxart: Slightly Cautious, Mostly Bullish
I'm bullish on $VXRT